Home » Topics » Regulatory » Patents

Patents
RSS

Isis Innovation presents new dsNA molecules for Parkinson's disease

Oct. 31, 2012

New double-stranded RNA molecules disclosed for the treatment of cancer

Oct. 30, 2012

Japanese group patents novel anticancer CDC7 inhibitors

Oct. 30, 2012

IMPACT Therapeutics patents new PARP-1 inhibitors

Oct. 30, 2012

Atlanthera discloses new agents for cancer and other disorders

Oct. 30, 2012

Elara Pharmaceuticals discloses novel HIF-1-alpha inhibitors

Oct. 30, 2012

GlaxoSmithKline synthesizes new LSD1 inhibitors

Oct. 29, 2012

Prostetta Antiviral discloses novel agents for viral infections

Oct. 29, 2012

Novel bispecific antibodies patented by Boehringer Ingelheim

Oct. 29, 2012

Universitat Stuttgart presents new fusion proteins

Oct. 29, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...